MarketCap
Facebook
X
Telegram
Ocean Bio-Chem Income Statement 2021-2009 | OBCI
Brief overview of financial results at Ocean Bio-Chem
The comparison covers a five-year financial horizon. Revenue at Ocean Bio-Chem moved from $1.9 million in 2016 to $64.3 million in 2021. Across the full period, sales moved by +3375.6%; the average annual rate was 103.3%. Sales grew at a rate typical of a strong expansion phase.
The gross result shifted from $13.9 million to $24.3 million, or +75.1%. The cost base moved more slowly than the top line, which supported margins. The gross margin was 749.9% at the start and 37.8% at the end. Weakening gross profitability reduces the quality of the top-line trend.
The five-year EBITDA result moved by +203.3%: from 4.1 million dollars to 12.3 million dollars. EBITDA underperformed the top-line trend. At the operating-margin level, the figure shifted from 220% to 19.2%. The margin contraction indicates weaker operating efficiency.
The five-year change in net income was +301.1%: from $2.1 million to $8.4 million. Net earnings remained broadly steady over the period.
Market capitalization changed from $35.9 million to $82.4 million (+129.9%). Market value lagged the financial performance.
Financial takeaway
The financial profile remains mixed, with strengths and risks moving in different directions. The strongest signals are revenue expansion and improving net profitability. The main areas of concern are weaker gross profitability and a declining EBITDA margin. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Ocean Bio-Chem
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
82.4 M | 98.2 M | 46.2 M | 33 M | 34.1 M | 35.9 M | 16.4 M | 40.8 M | 22.6 M | 18.2 M | 19.4 M | - | - |
Shares |
9.49 M | 9.46 M | 9.39 M | 9.28 M | 9.19 M | 9.06 M | 8.94 M | 8.83 M | 8.54 M | 8.23 M | 7.95 M | 7.79 M | - |
Historical Prices |
8.69 | 10.4 | 4.92 | 3.56 | 3.71 | 3.96 | 1.83 | 4.61 | 2.64 | 2.22 | 2.44 | ||
Net Income |
8.4 M | 9.62 M | 3.5 M | 2.8 M | 2.6 M | 2.1 M | 461 K | 2.05 M | 1.46 M | 1.96 M | 2.39 M | 2.02 M | - |
Revenue |
64.3 M | 55.6 M | 42.3 M | 41.8 M | 37.9 M | 1.85 M | 2.08 M | 1.96 M | 1.83 M | 1.49 M | 1.76 M | - | - |
Cost of Revenue |
40 M | 32.1 M | 26.7 M | 837 K | 695 K | 22.3 M | - | - | - | - | - | - | - |
Gross Profit |
24.3 M | 23.5 M | 15.6 M | 14.4 M | 13.6 M | 13.9 M | 11.3 M | 12.1 M | 10.9 M | 10.6 M | 10.7 M | 9.38 M | - |
Operating Income |
10.9 M | 12.2 M | 4.61 M | 3.71 M | 3.68 M | 3.1 M | 750 K | 3.02 M | 2.31 M | 3.08 M | 3.71 M | 3.25 M | - |
Interest Expense |
149 K | 132 K | 119 K | 122 K | -2.06 K | 17.8 K | 33.6 K | 43.5 K | 67.2 K | 98 K | 150 K | 116 K | - |
EBITDA |
12.3 M | 13.5 M | 5.9 M | 4.88 M | 4.63 M | 4.07 M | 1.67 M | 3.87 M | 3.09 M | 3.78 M | 4.47 M | 3.94 M | - |
Operating Expenses |
13.4 M | 11.3 M | 11 M | 10.7 M | 9.96 M | 10.8 M | 10.6 M | 9.11 M | 8.58 M | 7.54 M | 6.97 M | 6.13 M | - |
General and Administrative Expenses |
9.41 M | 8.36 M | 7.84 M | 7.64 M | 7.3 M | 7.66 M | 7.58 M | 6.54 M | 5.93 M | 5.13 M | 4.99 M | 4.5 M | - |
All numbers in USD currency
Quarterly Income Statement Ocean Bio-Chem
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | 9.51 M | 9.51 M | 9.5 M | 9.49 M | 9.48 M | 9.48 M | 9.48 M | 9.46 M | 9.46 M | 9.44 M | 9.44 M | 9.39 M | 9.37 M | 9.36 M | 9.34 M | 9.27 M | 9.26 M | 9.25 M | 9.25 M | 9.22 M | 9.15 M | 9.15 M | 9.15 M | 9.1 M | 9.01 M | 8.99 M | - | 8.94 M | 8.92 M | 8.92 M | - | 8.91 M | 8.82 M | 8.69 M | - | 8.61 M | 8.49 M | 8.4 M | - | 8.29 M | 8.2 M | 8.11 M | - | 8 M | 7.9 M | 7.85 M |
Net Income |
- | - | -321 K | 1.3 M | - | 3.27 M | 2.6 M | 1.9 M | - | 4.66 M | 3.45 M | 627 K | - | 1.12 M | 1.01 M | 715 K | - | 1.27 M | 1.12 M | 523 K | - | 854 K | 953 K | 504 K | - | 1.53 M | 657 K | -541 K | - | 296 K | 114 K | -15.9 K | - | 903 K | 411 K | 224 K | - | 622 K | 173 K | 349 K | - | 771 K | 363 K | 364 K | - | 1.14 M | 389 K | 648 K |
Revenue |
- | - | 15.2 M | 12.7 M | - | 21.5 M | 15.7 M | 13.1 M | - | 19.2 M | 15.7 M | 7.82 M | - | 12.5 M | 10.9 M | 9.08 M | - | 13.2 M | 11.4 M | 820 K | - | 239 K | 539 K | 747 K | - | 263 K | 460 K | 546 K | - | 198 K | 493 K | 725 K | - | 466 K | 295 K | 713 K | - | 397 K | 469 K | 471 K | - | 386 K | 384 K | 6 M | - | 9.88 M | 8.22 M | 6.73 M |
Cost of Revenue |
- | - | 9.86 M | 8 M | - | 14 M | 8.42 M | 7.75 M | - | 10.4 M | 7.99 M | 4.68 M | - | 8.1 M | 6.43 M | 5.66 M | - | 8.67 M | 6.74 M | 5.41 M | - | 7.54 M | 5.62 M | 5.26 M | - | 7.31 M | 5.05 M | 4.37 M | - | 7.27 M | 5.57 M | 3.97 M | - | 6.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | 5.35 M | 4.74 M | - | 7.45 M | 7.27 M | 5.38 M | - | 8.75 M | 7.71 M | 3.14 M | - | 4.41 M | 4.52 M | 3.42 M | - | 4.51 M | 4.65 M | 2.98 M | - | 4.11 M | 4.28 M | 3.13 M | - | 4.9 M | 3.67 M | 2.38 M | - | 3.56 M | 3.16 M | 2.04 M | - | 3.59 M | 3.43 M | 2.09 M | - | 3.18 M | 2.97 M | 2.24 M | - | 3.26 M | 2.86 M | 2.14 M | - | 3.35 M | 2.98 M | 2.51 M |
Operating Income |
- | - | -329 K | 1.66 M | - | 4.21 M | 3.37 M | 2.47 M | - | 5.99 M | 4.4 M | 691 K | - | 1.47 M | 1.33 M | 954 K | - | 1.68 M | 1.47 M | 672 K | - | 1.26 M | 1.4 M | 742 K | - | 2.21 M | 1.01 M | -820 K | - | 447 K | 176 K | -769 | - | 1.34 M | 582 K | 352 K | - | 996 K | 274 K | 525 K | - | 1.18 M | 620 K | 621 K | - | 1.63 M | 647 K | 1.03 M |
Interest Expense |
- | - | 79.1 K | 31.7 K | - | 35.8 K | 40.8 K | 37.2 K | - | 39.6 K | 38.2 K | 15.9 K | - | 31.2 K | 35.4 K | 29.8 K | - | 52.9 K | 33.7 K | 7.39 K | - | 259 | 942 | 1.95 K | - | 3.93 K | 4.91 K | 5.88 K | - | 7.89 K | 8.82 K | 10.1 K | - | 10.3 K | 10.1 K | 11.4 K | - | 16.2 K | 18.2 K | 17.4 K | - | 22.1 K | 25.8 K | 27.7 K | - | 34.8 K | 47.4 K | 25.8 K |
EBITDA |
- | - | 537 K | 2.07 M | - | 5.31 M | 4.09 M | 2.82 M | - | 7.01 M | 5.08 M | 1.02 M | - | 2.44 M | 1.98 M | 1.28 M | - | 2.53 M | 1.99 M | 911 K | - | 1.99 M | 1.89 M | 989 K | - | 2.94 M | 1.5 M | -573 K | - | 1.13 M | 622 K | 221 K | - | 1.96 M | 989 K | 553 K | - | 1.58 M | 650 K | 711 K | - | 1.7 M | 966 K | 793 K | - | 2.21 M | 1.07 M | 1.25 M |
Operating Expenses |
- | - | 5.68 M | 3.07 M | - | 3.25 M | 3.91 M | 2.91 M | - | 2.75 M | 3.3 M | 2.45 M | - | 2.93 M | 3.19 M | 2.47 M | - | 2.83 M | 3.18 M | 2.31 M | - | 2.85 M | 2.88 M | 2.39 M | - | 2.69 M | 2.66 M | 3.2 M | - | 3.12 M | 2.99 M | 2.04 M | - | 2.26 M | 2.85 M | 1.74 M | - | 2.19 M | 2.7 M | 1.72 M | - | 2.09 M | 2.25 M | 1.52 M | - | 1.72 M | 2.33 M | 1.48 M |
General and Administrative Expenses |
- | - | 4.05 M | 2 M | - | 2.29 M | 2.64 M | 1.97 M | - | 2.03 M | 2.5 M | 1.71 M | - | 2.15 M | 2.21 M | 1.7 M | - | 2.11 M | 2.29 M | 1.55 M | - | 2.01 M | 1.98 M | 1.54 M | - | 1.91 M | 1.79 M | 2.49 M | - | 2.35 M | 2.06 M | 1.42 M | - | 1.62 M | 2.13 M | 1.15 M | - | 1.55 M | 1.88 M | 1.15 M | - | 1.31 M | 1.6 M | 1.06 M | - | 1.24 M | 1.67 M | 1.1 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Ocean Bio-Chem (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Conglomerates industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
NN
NNBR
|
$ 3.31 | -0.9 % | $ 164 M |  USA |
 |
Tejon Ranch Co.
TRC
|
$ 16.93 | -0.7 % | $ 455 M | USA |
 |
SGOCO Group, Ltd.
SGOC
|
- | -0.32 % | $ 718 M |  China |
 |
India Globalization Capital
IGC
|
$ 0.25 | -0.2 % | $ 22.2 M | USA |
 |
Alpha Metallurgical Resources
AMR
|
$ 137.16 | -4.62 % | $ 1.78 B | USA |
 |
Steel Partners Holdings L.P.
SPLP
|
- | 0.57 % | $ 756 M | USA |
 |
Cemtrex
CETX
|
$ 2.47 | -1.2 % | $ 327 K | USA |
 |
Compass Diversified
CODI
|
$ 10.08 | 0.3 % | $ 758 M | USA |
 |
Seaboard Corporation
SEB
|
$ 4 413.26 | -2.04 % | $ 4.25 B | USA |
 |
Icahn Enterprises L.P.
IEP
|
$ 7.79 | 1.04 % | $ 5.24 B | USA |
 |
Matthews International Corporation
MATW
|
$ 27.75 | - | $ 863 M | USA |